BET protein inhibitor JQ1 inhibits growth and modulates WNT signaling in mesenchymal stem cells

BACKGROUND: Efficacy and safety of anticancer drugs are traditionally studied using cancer cell lines and animal models. The thienodiazepine class of BET inhibitors, such as JQ1, has been extensively studied for the potential treatment of hematological malignancies and several small molecules belong...

Full description

Saved in:
Bibliographic Details
Published in:Stem Cell Res Ther
Main Authors: Alghamdi, Saeed, Khan, Irfan, Beeravolu, Naimisha, McKee, Christina, Thibodeau, Bryan, Wilson, George, Chaudhry, G. Rasul
Format: Artigo
Language:Inglês
Published: BioMed Central 2016
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4736146/
https://ncbi.nlm.nih.gov/pubmed/26830473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-016-0278-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items